Milestone Pharmaceuticals Inc (MIST) — Net Asset Quality Index
Milestone Pharmaceuticals Inc (MIST) has a Net Asset Quality Index of 23.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $87.75 Million minus total liabilities of $67.25 Million yields net assets of $20.50 Million. A higher index indicates a stronger, lower-leverage balance sheet. See MIST cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Milestone Pharmaceuticals Inc Net Asset Quality Index Over Time (2017–2024)
This chart shows how Milestone Pharmaceuticals Inc's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 23.4%, representing net assets of $20.50 Million against total assets of $87.75 Million USD. Explore cash efficiency ratio of Milestone Pharmaceuticals Inc to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Milestone Pharmaceuticals Inc (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for Milestone Pharmaceuticals Inc from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Milestone Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 17.4% | $13.15 Million | $75.50 Million | $62.35 Million | ▼ -4.9 pp |
| 2023 | 22.3% | $16.77 Million | $75.23 Million | $58.45 Million | ▼ -66.8 pp |
| 2022 | 89.1% | $66.35 Million | $74.48 Million | $8.13 Million | ▼ -4.9 pp |
| 2021 | 94.0% | $112.60 Million | $119.85 Million | $7.25 Million | ▼ -1.5 pp |
| 2020 | 95.4% | $143.12 Million | $149.97 Million | $6.86 Million | ▲ +2.3 pp |
| 2019 | 93.1% | $114.92 Million | $123.43 Million | $8.51 Million | ▲ +155.8 pp |
| 2018 | -62.7% | $-55.21 Million | $88.08 Million | $143.29 Million | ▲ +57.4 pp |
| 2017 | -120.0% | $-33.12 Million | $27.59 Million | $60.71 Million | — |